Relapse-Remitting MS May Soon Be Treated Using a Promising HDIT/HCT Method

The medical field was met by new findings in February 2017. The research trials showed that high dosage of immunosuppressive therapy coupled with a transplant of individual’s blood-forming stem cells could cause relapse-remitting multiple sclerosis (MS). This autoimmune disease is harmful to the human health as it triggers the immune system to attack the central nervous system.


The findings suggest that 69% of the trial patients who received the high dosage of immunosuppressive therapy and autologous hematopoietic transplant (HDIT/HCT) survived without showing any signs relapse, disability or brain lesions. These patients under trials did not take any MS medication. Other research findings suggest that the available MS drugs have a reduced success rate.


These results form the foundation for future research to proof the current suggestion that HDIT/HCT treatment can be more efficient for the treatment of MS patients than the long term use of available MS medications. The most notable symptoms of MS include weakness, fatigue, chronic pain, and speech difficulties with Relapsing-remitting MS being the most common form.


The research, HALT-MS, which was funded by the National Institute of Allergy and Infectious Diseases (NIAID), was conducted using a sample of 24 individuals with relapsing-remitting MS aged between 26 and 52 years. From the findings, HDIT/HCT medication is enough to treat MS patients. However, further research is required to evaluate the risks and benefits of HDIT/HCT.



Dr. Shiva Gopal Vasishta in Brief


Dr. Shiva Gopal Vasishta, MD, is a neurologist in Voorhees, NJ. Dr. Shiva Gopal Vasishta has 40 years of experience in diverse in neurology and psychiatry. His unmatched experience has earned him opportunities to serve in the Eastern Neurodiagnostic Association Pc and the Kennedy Health System Cherry Hill Campus.


Dr. Shiva Gopal Vasishta graduated from Government Medical College in 1979. He is known for accepting multiple insurance plans such as Aetna, Horizon Blue Cross Blue Shield, and Medicare. Dr. Shiva Gopal Vasishta is a big supporter of his native language, Spanish. He is a board certified neurologist.



Leave a Reply

Your email address will not be published. Required fields are marked *